Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

To investigate the etiology of depression occurring in the course of schizophrenia, 18 chronic schizophrenic outpatients with a major depressive episode were matched with nondepressed schizophrenic outpatient controls. There was no significant difference on mean equivalent daily dosage of chlorpromazine between the depressed and nondepressed schizophrenic groups. Thus, neuroleptics do not appear to induce depressive disorder in chronic schizophrenic patients.
 ...
PMID:Do neuroleptics cause depression? 614 54

The current study was devised to assess the utility of Research Diagnostic Criteria (RDC) categories used to classify minor mood disorders. Similar categories are to be used in the APA's Diagnostic and Statistical Manual, 3rd edition. The patient sample consisted of 64 consecutive admissions to a double-blind trial of amitriptyline, perphenazine and the combination as treatment for depression. Patients who met RDC for a current episode of major depressive disorder were given 4 weeks of pharmacotherapy as treatment. Chronic mood disorders were also assessed using RDC criteria. This evaluation revealed that only 34% met criteria for an episode of major depressive disorder alone, while 36% met criteria for intermittent depressive disorder, 14% for cyclothymic personality and 16% for labile personality in addition to being in a current major depressive episode. These 4 diagnostic subgroups were compared on demographic characteristics, childhood history, psychiatric history, presenting patterns of symptoms and social functioning, and response to treatment. Differences were noted in the subgroups in presenting symptom levels and residual impairment. However, there was no differential response to a brief course of antidepressant pharmacotherapy in patients with and without chronic minor mood disorders. Most patients showed an improvement during the brief course of treatment. Thus, the presence of a chronic minor mood disorder does not appear to be contraindication for use of medication in patients who also are currently experiencing a major depressive episode.
 ...
PMID:Chronic mood disorders in depressed outpatient--diagnosis and response to pharmacotherapy. 644 86

The dexamethasone suppression test (DST) was given to 33 elderly, male outpatients, previously diagnosed by DSM-III criteria as having dementia. Fifteen of these patients also had signs and symptoms of depression and, except for the presence of organic mental syndrome, would have met DSM-III criteria for major depressive episode. Of these 15 depressed, demented patients, 40% had abnormal DST results. None of the 18 patients who had dementia alone had abnormal DSTs. Our data suggest that in elderly, demented outpatients, an abnormal DST may be associated with concomitant depression.
 ...
PMID:The dexamethasone suppression test in demented outpatients with and without depression. 658 Jun 62

In a matched controlled study 72 Canadian patients with a major depressive episode were compared with non-depressed and never depressed orthopedic patients. Significantly more of the depressives had parental loss before 17 years of age, a poor marriage before the onset of depression and a family history of depression.
 ...
PMID:Risk factors for depression in Canadians. 670 78

Two sisters developed benign intracranial hypertension (BIH) two weeks following the resolution of a major depressive episode. The association of BIH and a major affective disorder in genetically related individuals has not been previously reported to our knowledge. Both conditions are associated with disturbances in the hypothalamic-pituitary-adrenal axis. Falling corticosteroid levels in a resolving depression may result in impaired cerebrospinal fluid absorption and subsequent BIH.
 ...
PMID:Familial benign intracranial hypertension and depression. 709 25

The authors studied the validity of a low dose (0.5 mg) dexamethasone suppression test (DST) in identifying depression. Nine patients who met the criteria of major depressive episode (MDE) in the Diagnostic and Statistical Manual of Mental Disorders, another nine psychiatric patients and one normal subject underwent the DST. At least one of the two blood samples obtained either at 8 a.m. or at 2 p.m. from each of the nine patients with MDE showed a cortisol concentration of over 5.0 micrograms/dl, while the cortisol concentration in the other 10 subjects was uniformly suppressed under this level. All the patients with MDE could be identified by nonsuppression of the cortisol secretion at 8 a.m. or at 2 p.m. An "early escape" phenomenon in depressed patients reported by Carroll et al. (1976) was absent in a 0.5 mg DST, and the blood samples at 8 p.m. were less useful for identifying the depressive patient. The reason why the one point sampling method used by previous investigators was insufficient to identify the depressed patient was discussed.
 ...
PMID:Major depressive episode and low dose dexamethasone suppression test. 712 57

Based on the observation that Hispanic depressed patients appear to receive lower dosages of antidepressants, the clinical records of 41 Hispanic and 21 Anglo, female outpatients receiving antidepressants were compared. All the patients had been diagnosed by two psychiatrists as suffering from a major depressive episode according to the DSM III criteria. The records showed that the Anglo patients received about double the dosage of antidepressants given to the Hispanic patients. The Hispanic patients complained more about side effects, but the treatment outcome was comparable in both groups. Apart from pharmacokinetic factors, the authors suggest that these clinical observations may be due to the fact that Hispanic depressed patients express depression in terms of somatic symptoms which are often similar to the side effects produced by antidepressants. Clinicians ought to familiarize themselves with the psychological, sociocultural, and biologic characteristics of the patient, and should approach the chemotherapy in a differential manner. Controlled prospective studies should be designed to test the hypotheses generated by this study.
 ...
PMID:Pharmacotherapy of Hispanic depressed patients: clinical observations. 715 73

Tourette syndrome (TS) is a common, neuropsychiatric disorder which has many similarities to attention deficit hyperactivity disorder (ADHD). TS probands have a high frequency of a variety of behavioral disorders including depression. The depression may be due to a pleiotrophic effect of the Gts genes, proband ascertainment bias, or a result of coping with the chronic tics. To distinguish between these hypotheses we examined the responses to 17 Diagnostic Interview Schedule questions to evaluate the 9 DSM-III-R criteria for major depressive episode in 1,080 adults consisting of TS and ADHD probands, their relatives and controls. Using a Bonferonni corrected p there was a significant progressive increase in 16 of 17 depressive symptoms and for a life time history of a major depressive episode in groups with increased genetic loading for Gts genes. Similar trends were seen in the small number of ADHD probands and their relatives. There was also a significant increase for these variables in non-proband TS relatives versus non-TS relatives, indicating the association of depression with Gts genes was not due to ascertainment bias or the inappropriate choice of controls. Multiple linear regression analysis indicated that obsessive-compulsive behaviors, sex, ADHD, drug abuse, and age all showed a more significant effect on depressive symptoms than the number of tics. The presence or absence of TS in the relatives had a much greater effect on risk for depression than the presence or absence of an episode of major depression in the proband. These results are consistent with the hypothesis that Gts and ADHD genes play a major role in depression.
 ...
PMID:Role of genetic factors in depression based on studies of Tourette syndrome and ADHD probands and their relatives. 748 44

We examined the risk of attempted suicide in 100 inpatients during a major depressive episode. We hypothesized that patients who attempt suicide have a vulnerability for suicidal behavior independent of severity or duration of depression, manifested by suicide attempts early in the course of a depressive episode. The first 3 months after the onset of an MDE and the first 5 years after the lifetime onset of major depressive disorder represented the highest-risk period for attempted suicide, independent of the severity or duration of depression. Familial, genetic, early-life loss experiences and comorbid alcoholism may be causal factors.
 ...
PMID:Major depression and the risk of attempted suicide. 756 May 45

Depression recurs in three quarters of cases; it is therefore necessary to undertake long-term studies in order to understand the clinical and epidemiological implications. Current classifications schematically distinguish depressive episodes according to their more or less permanent and complete semiological expression (at least five symptoms over at least two weeks for a major depressive episode, versus at least two criteria for the greater part of the time over at least two years) or their time-scale (isolated or recurrent episodes; recurrent brief depressive episodes...). The terminology of therapeutic strategies is based on the temporal definitions of the depressive process. Thus one speaks of curative treatment during the acute phase of the illness (two months), maintenance treatment during recurrence (four to six months), and prophylaxis against later possible recurrences (more than six months). Epidemiological findings emphasize the importance not only of recurrence of depression (50% in the year following an index episode), but also that of becoming chronic (20%), of partial remissions (15 to 20%), and the "bipolarisation" of a unipolar illness (10 to 15%). Finally, certain risk factors for recurrence have been identified. The most important of these is a large number of previous depressive episodes.
 ...
PMID:[The long-term course of depression (epidemiology and clinical aspects)]. 758 81


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>